References
- 1. “The International Classification Of Sleep Disorders, Revised Diagnostic and Coding Manual”. Produced by the American Academy of Sleep Medicine in association with the European Sleep Research Society, Japanese Society Of Sleep, Research Latin American Sleep Society, 2001, pp.52-58.
- 2. http://www.carmipharmacy.com/services/sleepapnea/ - accesat la date de 01.03.2018.
- 3. Wellman A, et al. “Ventilatory control and airway anatomy in obstructive sleep apnoea. Am J Respir Crit Care Med. 2004;170:1225–1232.
- 4. Patrick A Lévy, et al. Obstructive sleep apnoea syndrome. Nature Reviews Disease Primers. (2015). 1. 10.1038/nrdp.2015.24.
- 5. Susheel P. Patil, et al. “Adult Obstructive Sleep Apnea Pathophysiology and Diagnosis” Chest. 2007 Jul; 132(1): 325.
- 6. Fogel RB, et al. “The effect of sleep onset on upper airway muscle activity in patients with sleep apnoea versus controls.” J Physiol. 2005;564:549–562.
- 7. Strohl KP. “Upper airway muscles of respiration.”Am Rev Respir Dis, 1981; 124: 211–213.
- 8. Fogel RB, et al. Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004;59:159–163.
- 9. Cole A; et al. “A new grading of Pierre Robin sequence.” Cleft Palate Craniofac J. 2008; 45(6):603-6.
- 10. Sally R. Shott. “Obstructive Sleep Apnea in Children with Down Syndrome: Why does my child need a sleep study?.” Cincinnati Children's Hospital University of Cincinnati Department of Otolaryngology Head and Neck Surgery.
- 11. Trotter TL, Hall JG. “Health supervision for children with achondroplasia.” Pediatrics. 2005 Sep; 116(3):771-83. Erratum in: Pediatrics. 2005 Dec;116(6):1615.
- 12. Wright MJ, Irving MD. “Clinical management of achondroplasia.” Arch Dis Child. 2012 Feb;97(2):129-34.10.1136/adc.2010.189092
- 13. Vajo Z, et al. “The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.” Endocr Rev. 2000 Feb;21(1):23-39. Review.
- 14. Mary Ann Yantis; Jacquelin Neatherlin. “Obstructive Sleep Apnea in Neurological Patients.” J NeurosciNurs. 2005;37(3):150-155.
- 15. Sharafkhaneh A, et al. “Association of psychiatric disorders and sleep apnoea in a large cohort.” Sleep. 2005; 28(11):1405–1411.
- 16. McCallW, et al. “Correlates of depressive symptoms in patients with obstructive sleep apnoea.” J Clin Sleep Med. 2006;2:424–6.
- 17. Virend K. Somers, et al. “Sleep Apnea and Cardiovascular Disease.” Journal of the American College of Cardiology Vol. 52, No. 8, 2008, pp.686-717, by the American Heart Association, Inc, and the American College of Cardiology Foundation, Published by Elsevier Inc., doi:10.1016/j.jacc.2008.05.002.10.1016/j.jacc.2008.05.002
- 18. Peppard PE, et al. “Prospective study of the association between sleep-disordered breathing and hypertension.” N Engl JMed. 2000;342:1378–1384.
- 19. Prisant LM, et al. “Obstructive sleep apnoea syndrome.” J Clin Hypertens (Greenwich), 2006 Oct; 8(10):746-50.
- 20. Logan AG, et al. “High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.” J Hypertens. 2001;19: 2271–227710.1097/00004872-200112000-00022
- 21. Fernando De Torres-Alba, et al. “Obstructive Sleep Apnea and Coronary Artery Disease: From Pathophysiology to Clinical Implications.” Pulmonary Medicine Volume 2013.
- 22. Lavie P, Hoffstein V. “Sleep apnoea syndrome: a possible contributing factor to resistant hypertension.” Sleep. 2001;24:721–725.10.1093/sleep/24.6.721
- 23. Genevieve C Digby, Adrian Baranchuk. “Sleep Apnea and Atrial Fibrillation.” 2012 Update Curr Cardiol Rev. 2012 Nov; 8(4): 265–272.
- 24. Dyken ME, et al. “Investigating the relationship between stroke and obstructive sleep apnoea.” Stroke. 1996; 27: 401–407.10.1161/01.STR.27.3.401
- 25. Foster GE, et al. “Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnoea.” Am J Respir Crit CareMed. 2007; 175: 720–725
- 26. Canessa N., et al. “Obstructive sleep apnoea: brain structural changes and neurocognitive function before and after treatment.” American Journal of Respiratory and Critical Care Medicine. 2011;183(10):1419–1426.
- 27. Turkington PM, et al. “Prevalence and predictors of upper airway obstruction in the first 24 hours after acute stroke.” Stroke. 2002; 33: 2037–204210.1161/01.STR.0000023576.94311.27
- 28. Palombini L, Guilleminault C. “Stroke and treatment with nasal CPAP.” Eur J Neurol. 2006; 13: 198–200.10.1111/j.1468-1331.2006.01169.x
- 29. Sahlin C, et al. “Obstructive sleep apnoea is a risk factor for death in patients with stroke.” Arch Intern Med. 2008; 168: 297–301.
- 30. David Filgueiras-Rama, et al. “Arrhythmias in Obstructive Sleep Apnea: Underlying Mechanisms and Implications in the Clinical Setting.” PulmonaryMedicine Volume 2013.
- 31. Ludka O, et al. “Sleep apnoea prevalence in acute myocardial infarction--the Sleep Apnea in Post-acute Myocardial Infarction Patients (SAPAMI).” Study Int J Cardiol. 2014 Sep;176(1):13-9.
- 32. Gami AS., et al. “Day-night pattern of sudden death in obstructive sleep apnoea.” N Engl J Med. 2005 Mar 24; 352(12):1206-14.
- 33. Babak Mokhlesi, Naresh M. Punjabi. “REM-related” Obstructive Sleep Apnea: An Epiphenomenon or a Clinically Important Entity?” Sleep. 2012 Jan 1; 35(1): 5–7.
- 34. Ip MS, et al. “Obstructive sleep apnoea is independently associated with insulin resistance.” Am J Respir Crit CareMed. 2002;165 (5):670–676
- 35. Anch AM, et al. “Supraglottic airway resistance in normal subjects and patients with occlusive sleep apnoea.” J Appl Physiol: Respirat Environ Exercise Physiol 1982; 53: 1158-1163.
- 36. Lavie P, et al. “Breathing disorders in sleep associated with “microarousals' in patients with allergic rhinitis.” Acta Otolaryngol. 1981 Nov-Dec;92(5-6):529-33